These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32885989)

  • 1. Data driven CRO benchmarking for biomarker analysis.
    Dolman A; Yu X; Gusev AI
    Bioanalysis; 2020 Aug; 12(16):1117-1127. PubMed ID: 32885989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRO benchmarking for clinical biomarker analysis outsourcing.
    Yu X; Gusev AI
    Bioanalysis; 2019 Jul; 11(14):1309-1313. PubMed ID: 31475870
    [No Abstract]   [Full Text] [Related]  

  • 3. 11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation.
    Islam R; Briscoe C; Bower J; Cape S; Arnold M; Hayes R; Warren M; Karnik S; Stouffer B; Xiao YQ; van der Strate B; Sikkema D; Fang X; Tudoroniu A; Tayyem R; Brant A; Spriggs F; Barry C; Khan M; Keyhani A; Zimmer J; Caturla MC; Couerbe P; Khadang A; Bourdage J; Datin J; Zemo J; Hughes N; Fatmi S; Sheldon C; Fountain S; Satterwhite C; Colletti K; Vija J; Yu M; Stamatopoulos J; Lin J; Wilfahrt J; Dinan A; Ohorodnik S; Hulse J; Patel V; Garofolo W; Savoie N; Brown M; Papac D; Buonarati M; Hristopoulos G; Beaver C; Boudreau N; Williard C; Liu Y; Ray G; Warrino D; Xu A; Green R; Hayward-Sewell J; Marcelletti J; Sanchez C; Kennedy M; Charles JS; Bouhajib M; Nehls C; Tabler E; Tu J; Joyce P; Iordachescu A; DuBey I; Lindsay J; Yamashita J; Wells E
    Bioanalysis; 2018 Apr; 10(7):433-444. PubMed ID: 29701066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62).
    Piccoli S; Mehta D; Vitaliti A; Allinson J; Amur S; Eck S; Green C; Hedrick M; Hopper S; Ji A; Joyce A; Litwin V; Maher K; Mathews J; Peng K; Safavi A; Wang YM; Zhang Y; Amaravadi L; Palackal N; Thankamony S; Beaver C; Bame E; Emrich T; Grimaldi C; Haulenbeek J; Joyce A; Kakkanaiah V; Lanham D; Maher K; Mayer A; Trampont PC; Vermet L; Dakappagari N; Fleener C; Garofolo F; Rogers C; Tangri S; Xu Y; Liang M; Rajadhyaksha M; Richards S; Schweighardt B; Purushothama S; Baltrukonis D; Brumm J; Cherry E; Delcarpini J; Gleason C; Kirshner S; Kubiak R; Pan L; Partridge M; Pedras-Vasconcelos J; Qu Q; Skibeli V; Saunders TS; Staack RF; Stubenrauch K; Torri A; Verthelyi D; Yan H; Gorovits B; Palmer R; Milton M; Long B; Corsaro B; Farrokhi V; Fiscella M; Henderson N; Jawa V; McNally J; Murphy R; Waldner H; Yang TY
    Bioanalysis; 2019 Dec; 11(24):2207-2244. PubMed ID: 31820675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outsourcing bioanalytical services at Janssen Research and Development: the sequel anno 2017.
    Dillen L; Verhaeghe T
    Bioanalysis; 2017 Aug; 9(15):1195-1201. PubMed ID: 28762758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New, strategic outsourcing models to meet changing clinical development needs.
    Jones J; Minor M
    Perspect Clin Res; 2010 Apr; 1(2):76-9. PubMed ID: 21829788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sponsor relationships, analyte stability in ligand-binding assays and critical reagent management: a bioanalytical CRO perspective.
    Lefor Bradford J
    Bioanalysis; 2015; 7(11):1337-46. PubMed ID: 26110706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of Outsourcing Strategy and IT Technology in Clinical Trials.
    Stamenovic M; Dobraca A
    Acta Inform Med; 2017 Sep; 25(3):203-207. PubMed ID: 29114116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines (
    Kholmanskikh O; Wang YM; Hersey S; Wadhwa M; Block K; Bandukwala A; Szapacs M; Weiner R; Awwad K; Dessy F; Downing S; Du X; Garofolo F; Harris S; Hou V; Jones J; Kar S; Kinhikar A; Li M; Mathews J; Meissen J; Sumner GO; Pan L; Sanderink G; Scully I; Stanta J; Tanaka Y; Vauleon S; Wagner L; Wang K; Zhu L; Eck S; Lin YD; Azadeh M; Decman V; Diebold S; Du X; Goihberg P; Alcaide EG; Gonneau C; Hedrick MN; Hopkins G; Kar S; Loschko J; McCausland M; Mendez L; Sehra S; Stevens E; Sun YS; Tangri S; Trampont PC; Cludts I; Dysinger M; Kavita U; Sugimoto H; Chilewski S; Grimaldi C; Jiang Y; Kamerud J; Liu S; Owen C; Palackal N; Petit-Frere C; Pine S; Abhari MR; Scheibner K; Williams L; Xu T; Zhang G
    Bioanalysis; 2024; 16(8):179-220. PubMed ID: 38899739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Hennig M; Hundt F; Busta S; Mikus S; Sanden PH; Sörgel A; Ruppert T
    Ger Med Sci; 2017; 15():Doc02. PubMed ID: 28163667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of bioanalytical outsourcing: a pharma perspective.
    Bioanalysis; 2017 Aug; 9(15):1165-1169. PubMed ID: 28795582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis.
    Islam R; Kar S; Ritzén H; Hays A; Tayyem R; Barry C; Keyhani A; Zimmer J; Cruz Caturla M; Couerbe P; Warren M; Khadang A; Bourdage J; Lindley K; Williams D; Hughes N; Sheldon C; Satterwhite C; Vija J; Yu M; Boulay I; Stamatopoulos J; Lin J; Cape S; Estdale S; Thomas E; Dinan A; MacNeill R; Xiao YQ; Garofolo W; Savoie N; Brown M; Rhyne P; Hristopoulos G; Xu A; Goodwin L; Spriggs F; Xu A; Awaiye K; Hayes R; St Charles J; Bouhajib M; DiMarco C; DiMarco L; Savu SR; Bennett P; Kakkanaiah V; Nehls C; Stouffer B; Tabler E; Briscoe C; Karnik S; DuBey I; Kulagina N; Lindsay J; Beaver C; Williard C; Wang H; Feng H; Malone M; Wells E; Fang X; Moussallie M
    Bioanalysis; 2019 Apr; 11(7):645-653. PubMed ID: 30993999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles
    Sumner G; Keller S; Huleatt J; Staack RF; Wagner L; Azadeh M; Bandukwala A; Cao L; Du X; Salinas GF; Garofolo F; Harris S; Hopper S; Irwin C; Ji Q; Joseph J; King L; Kinhikar A; Lu Y; Luo R; Mabrouk O; Malvaux L; Marshall JC; McGuire K; Mikol V; Neely R; Qiu X; Saito Y; Salaun B; Scully I; Smeraglia J; Solstad T; Stoop J; Tang H; Teixeira P; Wang Y; Wright M; Mendez L; Beaver C; Eacret J; Au-Yeung A; Decman V; Dessy F; Eck S; Goihberg P; Alcaide EG; Gonneau C; Grugan K; Hedrick MN; Kar S; Sehra S; Stevens E; Stevens C; Sun Y; McCush F; Williams L; Fischer S; Wu B; Jordan G; Burns C; Cludts I; Coble K; Grimaldi C; Henderson N; Joyce A; Lotz G; Lu Y; Luo L; Neff F; Sperinde G; Stubenrauch KG; Wang Y; Ware M; Xu W
    Bioanalysis; 2023 Aug; 15(15):861-903. PubMed ID: 37584363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update to the European Bioanalysis Forum recommendation on biomarkers assays; bringing context of use into practice.
    Goodman J; Cowan KJ; Golob M; Karlsson L; Kunz U; Nelson R; Ulrichts H; Stevenson L; Terry L; Timmerman P
    Bioanalysis; 2020 Oct; 12(20):1427-1437. PubMed ID: 33025797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations on qPCR/ddPCR assay validation by GCC.
    Wissel M; Poirier M; Satterwhite C; Lin J; Islam R; Zimmer J; Khadang A; Zemo J; Lester T; Fjording M; Hays A; Hughes N; Garofolo F; Guilbaud R; Groeber E; Renfrew H; Colletti K; Yu M; Lin J; Fang X; Shah S; Garofolo W; Kar S; Hayes R; Pirro J; Kane C; Luna M; Xu A; Cape S; O'Dell M; Wheller R; Ritzen H; Vance J; Farley E; Matys K; Tabler E; Mylott W; Yuan M; Karnik S; Voelker T; DuBey I; Williard C; Shi J; Yamashita J
    Bioanalysis; 2022 Jun; 14(12):853-863. PubMed ID: 35703321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug development process and COVID-19 pandemic: Flourishing era of outsourcing.
    Wasan H; Singh D; Reeta KH; Gupta P; Gupta YK
    Indian J Pharmacol; 2022; 54(5):364-372. PubMed ID: 36537406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioanalytical outsourcing: transitioning from Pharma to CRO.
    Hayes R
    Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
    [No Abstract]   [Full Text] [Related]  

  • 18. From challenges to solutions. European Bioanalysis Forum 3rd Annual Open Symposium, Hesperia Towers, Barcelona, Spain, 1-3 December 2010.
    Abbott RW; Gordon B; van Amsterdam P; Lausecker B; Brudny-Kloeppel M; Smeraglia J; Romero F; Globig S; Golob M; Knutsson M; Herling C; Vieser E; Timmerman P
    Bioanalysis; 2011 Apr; 3(8):833-8. PubMed ID: 21510756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-Based Monitoring: Key Conditions in Collaboration Between Contract Research Organization and Sponsor.
    Wolfs M; Bambic A; Lange BS; Galante K; Plaza RS; O'Conallain C; Racaro G; Giblin M; Djali S
    Ther Innov Regul Sci; 2019 Jul; 53(4):512-518. PubMed ID: 30157695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of contract research organizations in translational medicine.
    Shih MS
    J Orthop Translat; 2015 Apr; 3(2):85-88. PubMed ID: 30035044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.